Welcome to our dedicated page for Cno Finl Group SEC filings (Ticker: CNO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CNO Financial Group filings document the insurance holding company's operating results, governance and capital actions. Form 8-K reports furnish quarterly financial results, financial supplements and operating presentations covering life and health insurance, annuities, distribution activity, investment results and capital management.
Proxy and governance filings address annual meeting voting items, director elections, board committee matters, executive compensation and director compensation. Other material-event reports disclose dividend declarations, board appointments or retirements, Regulation FD presentations and securities identified in the company's capital structure.
CNO Financial Group, Inc. reported the results of its 2026 Annual Meeting of Shareholders held on May 12, 2026. Shareholders elected nine directors to one-year terms ending at the 2027 annual meeting, with each nominee receiving over 80 million votes in favor and only modest opposition.
Shareholders also approved, on a non-binding advisory basis, the executive compensation of the company’s named executive officers, with 79,637,913 votes for, 1,675,840 against, and 168,450 abstentions. In addition, they ratified the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for 2026, with 83,949,859 votes for, 1,766,276 against, and 58,887 abstentions.
Brown Archie M reported acquisition or exercise transactions in this Form 4 filing.
CNO Financial Group director Archie M. Brown received an equity grant. On May 12, 2026, he was awarded 3,574 shares of common stock as immediately vesting restricted stock units under CNO’s Amended and Restated Long-Term Incentive Plan at a reference price of $46.17 per share. Following this grant, he directly owns 20,337 shares of CNO common stock.
CNO Financial Group, Inc. director Adrianne Lee reported a compensation-related equity grant. On May 12, 2026, Lee acquired 3,574 shares of Common Stock at a value of $46.17 per share through an award of immediately vesting restricted stock units under the company’s Amended and Restated Long-Term Incentive Plan. Following this award, Lee directly holds 20,337 shares of CNO common stock. This was not an open-market purchase but part of the company’s long-term incentive compensation program.
Foss David B reported acquisition or exercise transactions in this Form 4 filing.
CNO Financial Group, Inc. director David B. Foss, through the Foss Management Trust, received an award of 3,574 shares of Common Stock at an indicated value of $46.17 per share. The award consists of immediately vesting restricted stock units granted under the company’s Amended and Restated Long-Term Incentive Plan, bringing indirect holdings to 52,725 shares.
Maurer Daniel R reported acquisition or exercise transactions in this Form 4 filing.
CNO Financial Group director Daniel R. Maurer reported new equity compensation and updated holdings. He received an award of 6,043 shares of Common Stock as immediately vesting restricted stock units under the CNO Financial Group, Inc. Amended and Restated Long-Term Incentive Plan at a value of $46.17 per share. Following this grant, he directly holds 108,102 shares. A separate entry shows 24,624 shares of Common Stock held indirectly through the Daniel R. Maurer Revocable Trust, reflecting indirect ownership rather than a new market transaction.
CNO Financial Group, Inc. director Ragavan Chetlur S received an equity award in the form of common stock. On May 12, 2026, he was granted 3,574 shares of common stock at a reference price of $46.17 per share, classified as a grant or award acquisition.
The footnote explains this was an award of immediately vesting restricted stock units granted under the company’s Amended and Restated Long-Term Incentive Plan. Following this award, his directly held common stock position increased to 33,325 shares, reflecting routine, compensation-related equity rather than an open‑market purchase.
CNO Financial Group director Steven E. Shebik received an equity award of 3,574 shares of common stock as compensation. The award is described as immediately vesting restricted stock units granted under the CNO Financial Group, Inc. Amended and Restated Long-Term Incentive Plan.
After this grant, Shebik directly holds 56,756 shares of CNO common stock. The filing classifies the transaction as a grant or award acquisition, not an open-market purchase or sale, making this a routine compensation-related update to his equity position.
Turner Jessica A reported acquisition or exercise transactions in this Form 4 filing.
CNO Financial Group director Jessica A. Turner received a grant of 3,574 shares of Common Stock as equity compensation. The award consists of immediately vesting restricted stock units granted under the CNO Financial Group, Inc. Amended and Restated Long-Term Incentive Plan. Following this grant, Turner directly holds 10,584 shares of CNO common stock.
Gibson Linda T. reported acquisition or exercise transactions in this Form 4 filing.
CNO Financial Group, Inc. director Linda T. Gibson reported an equity award of 3,574 shares of common stock on May 12, 2026. The award was valued at $46.17 per share and was granted as immediately vesting restricted stock units under the company’s Amended and Restated Long-Term Incentive Plan.
Following this grant, Gibson’s indirect holdings through the Linda T. Gibson Revocable Trust Agreement increased to 4,817 shares of CNO common stock. This is a compensation-related award rather than an open‑market share purchase or sale.
CNO Financial Group, Inc. filed a Form 13F reporting its institutional holdings as of the reporting period. The filing lists 18 holdings with a total market value of $174,426,642 and names 40/86 Advisors, Inc. as an other included manager. The report was signed by Joel T. Koehneman on 05-13-2026.